EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting histone methylation and demethylation for non-alcoholic fatty liver disease

Yuanbing Du, Zhangxu He, Sasa Jin, Gang Jin, Kaiyue Wang, Feifei Yang, Jingyu Zhang

Bioorganic Chemistry · 2024

DOI: 10.1016/j.bioorg.2024.107698 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioorganic Chemistry, 2024. Verfasst von Yuanbing Du und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy College, Henan University of Chinese Medicine, 450046 Zhengzhou, PR China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Histones. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide, facing increasing challenges in terms of prevention and treatment. The methylation of lysine and arginine residues on histone proteins is dynamically controlled by histone methyltransferases (HMTs) and histone demethylases (HDMs), regulating chromatin structure and gene transcription. Mutations, genetic translocations, and altered gene expression involving HMTs and HDMs are frequently observed in NAFLD. HMTs and HDMs are receiving increasing attention in regulating NALFD. Targeting specific HMTs and HDMs for drug development is becoming a new strategy for treating NAFLD. This review provides a comprehensive summary of the regulatory mechanism of histone methylation/demethylation in NAFLD. Additionally, we discuss the potential applications of HMTs and HDMs inhibitors in preventing NAFLD, which may provide a scientific basis for the treatment of NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHistonesHumansMethylationHistone DemethylasesDemethylationAnimalsEnzyme InhibitorsHistone MethyltransferasesMolecular Structure

Stichwörter der Autor:innen

HDMHMTInhibitorsNAFLD

Substanzen

HistonesHistone DemethylasesEnzyme InhibitorsHistone Methyltransferases

Autor:innen und Institutionen

  • Pharmacy College, Henan University of Chinese Medicine, 450046 Zhengzhou, PR China.
  • Pharmacy College, Henan University of Chinese Medicine, 450046 Zhengzhou, PR China. Electronic address: hezhangxu123@163.com.
  • Pharmacy College, Henan University of Chinese Medicine, 450046 Zhengzhou, PR China. Electronic address: 276819657@qq.com.
  • Pharmacy College, Henan University of Chinese Medicine, 450046 Zhengzhou, PR China. Electronic address: jyzhang2004@126.com.

Förderung

  • China Postdoctoral Science Foundation

Zitieren

APA

Du, Y., He, Z., Jin, S., Jin, G., Wang, K., Yang, F., & Zhang, J. (2024). Targeting histone methylation and demethylation for non-alcoholic fatty liver disease. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2024.107698

Vancouver

Du Y, He Z, Jin S, Jin G, Wang K, Yang F, et al. Targeting histone methylation and demethylation for non-alcoholic fatty liver disease. Bioorganic Chemistry. 2024. doi:10.1016/j.bioorg.2024.107698

BibTeX
@article{Du2024,
  author = {Du, Yuanbing and He, Zhangxu and Jin, Sasa and Jin, Gang and Wang, Kaiyue and Yang, Feifei and Zhang, Jingyu},
  title = {Targeting histone methylation and demethylation for non-alcoholic fatty liver disease},
  journal = {Bioorganic Chemistry},
  year = {2024},
  doi = {10.1016/j.bioorg.2024.107698}
}
Kostenlos starten →